ABCG2 and cancer: We also studied whether ABCB1 (P-glycoprotein) and ABCG2 (BCRP, breast cancer resistance protein), which are usually considered the main drug transporters underlying the multidrug resistance (MDR) phenotype in cancer cells, compromise the antiproliferative effects of EF-24 in K562 cells.